Sunday newspaper round-up: Pandemic, Jobs, AstraZeneca
7th Jun 2020 12:21
(Sharecast News) - Fresh evidence of China's shocking cover-up of the pandemic outbreak has been found in censored media reports from Wuhan. Samples taken from sick patients and analysed by at least five laboratories had confirmed the existence of a lethal new coronavirus before China told global health authorities about an infectious disease that it claimed was unidentified. - Mail on Sunday
Read moreAstraZeneca strikes deals for more Covid-19 vaccine doses
5th Jun 2020 11:56
(Sharecast News) - AstraZeneca has signed deals to produce more than 1bn extra doses of Oxford University's Covid-19 vaccine including with two organisations backed by Bill and Melinda Gates.
Read moreMonday broker round-up
1st Jun 2020 13:47
(Sharecast News) - Johnson Matthey: Liberum downgrades to hold with a target price of 2,100p.
Read moreAstraZeneca clears regulatory hurdles with 'Brilinta' and 'Lynparza'
1st Jun 2020 07:37
(Sharecast News) - AstraZeneca announced on Monday that 'Brilinta', or ticagrelor, has been approved in the United States to reduce the risk of a first heart attack or stroke in high-risk patients with coronary artery disease (CAD) - the most common type of heart disease.
Read moreAstraZeneca upbeat on latest 'Tagrisso' trial results
29th May 2020 07:34
(Sharecast News) - AstraZeneca said on Friday that detailed results from the phase 3 'ADAURA' trial showed that 'Tagrisso', or osimertinib, demonstrated a "statistically significant and clinically meaningful improvement" in disease-free survival in the adjuvant treatment of patients with early-stage epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC), after complete tumour resection with curative intent.
Read moreInitial results of study into Oxford's Covid-19 vaccine imminent, AstraZeneca chief says
28th May 2020 18:19
(Sharecast News) - Some members of the Oxford University research team trying to develop a vaccine against the novel corona virus are already privy to initial results for early-stage human trials and their publication is imminent, AstraZeneca's chief said.
Read moreMerck to pursue Covid-19 vaccine using same approach as against Ebola
26th May 2020 12:33
(Sharecast News) - US pharmaceutical giant Merck has penned an agreement with researchers at IAVI to develop a vaccine candidate against the novel coronavirus which provokes Covid-19 using the same underlying technology as the ERVEBO vaccine for the Ebola virus.
Read moreSanofi to sell stake in Covid-19 treatment maker Regeneron
26th May 2020 11:59
(Sharecast News) - Sanofi will sell its stake in US-based maker of Covid-19 treatments Regeneron Pharmaceuticals.
Read moreOxford University's push for Covid-19 vaccine may stumble due to drop in infections
26th May 2020 11:53
(Sharecast News) - Oxford University's attempts to develop a vaccine against the novel coronavirus could run into an apparently unexpected hurdle, the head of its research team said.
Read moreNovavax begins trialling Covid-19 vaccine in Australia
26th May 2020 11:11
(Sharecast News) - Biotechnology firm Novavax has begun trialling a Covid-19 vaccine candidate in Australia as it hopes to release a proven vaccine by the end of 2020.
Read moreFauci predicts US could have vaccine by end of 2020
22nd May 2020 15:16
(Sharecast News) - Top White House health expert Anthony Fauci is confident that the US could begin to roll out a coronavirus vaccine by December.
Read moreFauci predicts US could have vaccine by end of 2020
22nd May 2020 15:16
(Sharecast News) - Top White House health expert Anthony Fauci is confident that the US could begin to roll out a coronavirus vaccine by December.
Read moreOxford University enrolling 10,260 more volunteers for late stage Covid-19 vaccine trials
22nd May 2020 12:43
(Sharecast News) - Oxford University and its partnership institutions have begun enrolling volunteers across Britain in the next phase of clinical trials for its vaccine against Covid-19.
Read moreAstraZeneca gets orphan drug designation for Enhertu
22nd May 2020 07:44
(Sharecast News) - AstraZeneca, alongside its partner Daiichi Sankyo, has been granted orphan drug designation status for 'Enhertu' in the US, it announced on Friday, for the treatment of patients with gastric cancer, including gastroesophageal junction cancer.
Read moreAstraZeneca gearing up to deliver Covid vaccine from September
21st May 2020 07:20
(Sharecast News) - AstraZeneca said on Thursday that it is collaborating with a number of countries and multilateral organisations to make the University of Oxford's vaccine "widely accessible" in an equitable way, having concluded the first agreements for at least 400 million doses.
Read more